|
COMMERCE BUSINESS DAILY ISSUE OF DECEMBER 17,1996 PSA#1743National Cancer Institute, Research Contracts Branch, PCCS 6120
Executive Blvd, EPS/635, Bethesda, MD 20892-7226 A -- PLCO CANCER SCREENING TRIAL-SCREENING CENTER SPECIAL STUDIES SOL
SEE BELOW POC Susan K. Hoffman, Contracting Officer, 301-496-8603. The
National Cancer Institute (NCI), Division of Cancer Prevention and
Control, Early Detection Branch intends to negotiate with the
Maimonides Medical Center, NY, N01-CN-25523; Georgetown University
Medical Center, DC, N01-CN-25522; Henry Ford Hospital, MI,
N01-CN-25512; Straub Pacific Health Foundation, HI, N01-CN-25515;
Marshfield Medical Research & Education Foundation, WI, N01-CN-25518;
University of Colorado Health Sciences Center, CO, N01-CN-25514;
University of Minnesota, MN, N01-CN-25513; University of Pittsburgh,
PA, N01-CN-25511; University of Utah, UT, N01-CN-25524 and Washington
University, MO, N01-CN-25516 for the inclusion of new work under the
current contracts. These are the Screening Centers under contract with
the NCI for performance of the Prostate, Lung, Colorectal and Ovarian
(PLCO) Screening Trial. Emerging issues which will affect NCIs ability
to operationalize the findings of the PLCO Trial need to be
investigated. These issues include but are not limited to quality of
life, cost-effectiveness and test performance and other integral
aspects of screening in large populations. Therefore, the statement of
work has been modified to include performance of special studies which
would determine quality of life, cost-effectiveness and test
performance. Authority: 41 USC 253(c)(1), as set forth in FAR
6.302-1(a)1. No collect calls will be accepted See Numbered Note(s):
22. (0348) Loren Data Corp. http://www.ld.com (SYN# 0008 19961217\A-0008.SOL)
A - Research and Development Index Page
|
|